Athanase Innovation AB (ATIN) - Total Liabilities
Based on the latest financial reports, Athanase Innovation AB (ATIN) has total liabilities worth Skr65.63 Million SEK (≈ $7.06 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Athanase Innovation AB - Total Liabilities Trend (2017–2025)
This chart illustrates how Athanase Innovation AB's total liabilities have evolved over time, based on quarterly financial data. See Athanase Innovation AB (ATIN) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Athanase Innovation AB Competitors by Total Liabilities
The table below lists competitors of Athanase Innovation AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lexibook Linguistic Electronic System SA
PA:ALLEX
|
France | €30.78 Million |
|
Optipharm.CO.LTD
KQ:153710
|
Korea | ₩15.37 Billion |
|
Silvano Fashion Group AS
WAR:SFG
|
Poland | zł12.73 Million |
|
Purple Innovation Inc
NASDAQ:PRPL
|
USA | $332.13 Million |
|
InBioGen Co Ltd
KO:101140
|
Korea | ₩2.44 Billion |
|
Dreamus Company
KQ:060570
|
Korea | ₩72.58 Billion |
|
Kworld Computer Co Ltd
TWO:3287
|
Taiwan | NT$373.31 Million |
|
IGM Biosciences Inc
NASDAQ:IGMS
|
USA | $6.06 Million |
Liability Composition Analysis (2017–2025)
This chart breaks down Athanase Innovation AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Athanase Innovation AB market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Athanase Innovation AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Athanase Innovation AB (2017–2025)
The table below shows the annual total liabilities of Athanase Innovation AB from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | Skr67.20 Million ≈ $7.23 Million |
+36.89% |
| 2024-06-30 | Skr49.09 Million ≈ $5.28 Million |
+38.85% |
| 2023-06-30 | Skr35.36 Million ≈ $3.81 Million |
+212.91% |
| 2022-06-30 | Skr11.30 Million ≈ $1.22 Million |
+7693.10% |
| 2021-06-30 | Skr145.00K ≈ $15.60K |
-99.97% |
| 2020-06-30 | Skr432.85 Million ≈ $46.58 Million |
-0.36% |
| 2019-06-30 | Skr434.40 Million ≈ $46.75 Million |
-0.01% |
| 2018-06-30 | Skr434.42 Million ≈ $46.75 Million |
-39.15% |
| 2017-06-30 | Skr713.87 Million ≈ $76.82 Million |
-- |
About Athanase Innovation AB
Athanase Innovation AB is public investment firm. The company invests in private and public technology and innovation companies. It also develops and sells machine inspection unit, used for automatic quality control, inspection and measurement of pallets. Athanase Innovation AB was founded in 2016 and is based in Stockholm, Sweden.